Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Allolio

Showing results (111-120 of 145) with videos related to

Pageof 15
Sort By:
The Journal of Clinical Endocrinology and Metabolism|July 28, 2010
High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumorsSilviu Sbiera, Sebastian Schmull, Guillaume Assie, et al.
Clinical Endocrinology|May 29, 2009
Assessment of serum-free cortisol levels in patients with adrenocortical carcinoma treated with mitotane: a pilot studyKrystallenia I Alexandraki, Gregory A Kaltsas, Carel W le Roux, et al.
The Journal of Clinical Endocrinology and Metabolism|January 14, 2016
Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice GuidelineStefan R Bornstein, Bruno Allolio, Wiebke Arlt, et al.
Cardiovascular Research|February 5, 2003
Effect of testosterone on post-myocardial infarction remodeling and functionMatthias Nahrendorf, Stefan Frantz, Kai Hu, et al.
The Journal of Clinical Endocrinology and Metabolism|October 4, 2014
Molecular and clinical evidence for an ARMC5 tumor syndrome: concurrent inactivating germline and somatic mutations are associated with both primary macronodular adrenal hyperplasia and meningiomaUlf Elbelt, Alessia Trovato, Michael Kloth, et al.
Plos One|September 14, 2011
Influence of short-term glucocorticoid therapy on regulatory T cells in vivoSilviu Sbiera, Thomas Dexneit, Sybille D Reichardt, et al.
Hypertension (Dallas, Tex. : 1979)|July 25, 2012
Observational study mortality in treated primary aldosteronism: the German Conn's registryMartin Reincke, Evelyn Fischer, Sabine Gerum, et al.
Deutsches Arzteblatt International|January 20, 2011
Deficits in the management of patients with adrenocortical carcinoma in GermanySarah Johanssen, Stefanie Hahner, Wolfgang Saeger, et al.
Diabetes|June 11, 2009
Urinary adiponectin excretion: a novel marker for vascular damage in type 2 diabetesMaximilian von Eynatten, Dan Liu, Cornelia Hock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 20, 2010
β-catenin activation is associated with specific clinical and pathologic characteristics and a poor outcome in adrenocortical carcinomaSébastien Gaujoux, Sophie Grabar, Martin Fassnacht, et al.
Pageof 15

Showing results (111-120 of 145) with videos related to

Sort By:
Pageof 15
The Journal of Clinical Endocrinology and Metabolism|July 28, 2010
High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumorsSilviu Sbiera, Sebastian Schmull, Guillaume Assie, et al.
Clinical Endocrinology|May 29, 2009
Assessment of serum-free cortisol levels in patients with adrenocortical carcinoma treated with mitotane: a pilot studyKrystallenia I Alexandraki, Gregory A Kaltsas, Carel W le Roux, et al.
The Journal of Clinical Endocrinology and Metabolism|January 14, 2016
Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice GuidelineStefan R Bornstein, Bruno Allolio, Wiebke Arlt, et al.
Cardiovascular Research|February 5, 2003
Effect of testosterone on post-myocardial infarction remodeling and functionMatthias Nahrendorf, Stefan Frantz, Kai Hu, et al.
The Journal of Clinical Endocrinology and Metabolism|October 4, 2014
Molecular and clinical evidence for an ARMC5 tumor syndrome: concurrent inactivating germline and somatic mutations are associated with both primary macronodular adrenal hyperplasia and meningiomaUlf Elbelt, Alessia Trovato, Michael Kloth, et al.
Plos One|September 14, 2011
Influence of short-term glucocorticoid therapy on regulatory T cells in vivoSilviu Sbiera, Thomas Dexneit, Sybille D Reichardt, et al.
Hypertension (Dallas, Tex. : 1979)|July 25, 2012
Observational study mortality in treated primary aldosteronism: the German Conn's registryMartin Reincke, Evelyn Fischer, Sabine Gerum, et al.
Deutsches Arzteblatt International|January 20, 2011
Deficits in the management of patients with adrenocortical carcinoma in GermanySarah Johanssen, Stefanie Hahner, Wolfgang Saeger, et al.
Diabetes|June 11, 2009
Urinary adiponectin excretion: a novel marker for vascular damage in type 2 diabetesMaximilian von Eynatten, Dan Liu, Cornelia Hock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 20, 2010
β-catenin activation is associated with specific clinical and pathologic characteristics and a poor outcome in adrenocortical carcinomaSébastien Gaujoux, Sophie Grabar, Martin Fassnacht, et al.
Pageof 15